The German Competition Authority imposes a fine on a pharmaceuticals distributor for having influenced in an anticompetitive way the resale prices for non-prescription pharmaceuticals (Bayer Vital)

Description of the impugned case The case deals with an indirect RPM clause: Bayer Vital concluded target agreements with several

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Daniela Seeliger, The German Competition Authority imposes a fine on a pharmaceuticals distributor for having influenced in an anticompetitive way the resale prices for non-prescription pharmaceuticals (Bayer Vital), 28 May 2008, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 31729

Visites 1473

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues